Stockscreener 앱 받기
8.9065
1.15%
-0.1035
시간 외 거래:
8.91
0.0035
+0.04%
전일 마감가:
$9.01
열려 있는:
$8.67
하루 거래량:
3,429
Relative Volume:
0.46
시가총액:
$42.21M
수익:
$1.28M
순이익/손실:
$280.60K
주가수익비율:
-111.33
EPS:
-0.08
순현금흐름:
-
1주 성능:
+1.79%
1개월 성능:
-2.45%
6개월 성능:
-6.74%
1년 성능:
+18.28%
1일 변동 폭
$8.67
$9.04
1주일 범위
$8.53
$9.2624
52주 변동 폭
$7.11
$10.04
Daxor Corporation Stock (DXR) Company Profile
명칭
Daxor Corporation
전화
212-330-8500
주소
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| DXR | 8.9065 | 42.21M | 1.28M | 280.60K | 0 | -0.08 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-05-16 | 개시 | Ascendiant Capital Markets | Buy |
Daxor Corporation 주식(DXR)의 최신 뉴스
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
(DXR) Long Term Investment Analysis - Stock Traders Daily
(DXR) On The My Stocks Page - Stock Traders Daily
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24 - The Manila Times
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC - GlobeNewswire
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Long Term Trading Analysis for (DXR) - Stock Traders Daily
Short Interest in Daxor Co. (NASDAQ:DXR) Rises By 39.6% - Defense World
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device - The Manila Times
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 - GlobeNewswire
Daxor (NYSEAMERICAN:DXR) Stock Passes Above Two Hundred Day Moving Average of $0.00 - Defense World
(DXR) Technical Data - Stock Traders Daily
Daxor announces review published in journal on BVA - TipRanks
Newly Published Review Highlights the Pivotal Role of - GlobeNewswire
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management - StockTitan
Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets - Defense World
Daxor secures $300K from LaunchTN for blood analyzer tech - Investing.com India
Daxor receives $300K matching fund award from Launch Tennessee - TipRanks
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee - GlobeNewswire
DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan
Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - TipRanks
Leading Central Florida Hospital Implements Daxor’s - GlobeNewswire
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care - StockTitan
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter - GlobeNewswire
Daxor reports doubled revenue, secures government contracts - Investing.com
Daxor reports doubled revenue, secures government contracts By Investing.com - Investing.com Canada
Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time - TipRanks
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network - GlobeNewswire
Daxor (DXR) Owner Earnings per Share (TTM) : 0.00 (As of Dec. 2023) - GuruFocus.com
Daxor (NASDAQ:DXR) Stock Price Down 4.6% - Defense World
Daxor Corporation Awarded $1.9M Contract by The U.S. Air - GlobeNewswire
Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor Expands to Three New Facilities as Blood Volume Analysis Technology Gains Momentum Nationwide - Marketscreener.com
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency - GlobeNewswire
Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer - StockTitan
Daxor awarded $550K matching-fund extension from U.S. DHA - TipRanks
Daxor Corp holds annual meeting, re-elects directors By Investing.com - Investing.com Canada
Daxor Corp holds annual meeting, re-elects directors - Investing.com
(DXR) Trading Report - Stock Traders Daily
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide - GlobeNewswire
Daxor’s BVA-100 blood volume diagnostic expands to three new centers - TipRanks
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress - Yahoo Movies UK
Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume ... - Yahoo Movies UK
Short Interest in Daxor Co. (NASDAQ:DXR) Grows By 15.2% - Defense World
Learn to Evaluate (DXR) using the Charts - Stock Traders Daily
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure ... - GlobeNewswire
Daxor Corporation (DXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.70%
3.32%
자본화:
|
볼륨(24시간):